Derivatives of protoberberine biological alkaloids and use of same inhibiting ulcerative colitis

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9266897
APP PUB NO 20150031717A1
SERIAL NO

14354019

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed are derivatives of protoberberine biological alkaloids or physiologically acceptable salts thereof produced by means of a derivative reaction of a source material of biological alkaline quaternary ammonium salts of protoberberine alkaloids, a preparation method for same and pharmaceutical uses thereof. The derivatives of protoberberine biological alkaloids or the physiologically acceptable salts thereof show activity inhibiting ulcerative colitis and can be used in the preparation of drugs for same.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF MEDICAL SCIENCESBEIJING 100050

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Deng, Anjun Beijing, CN 4 0
Li, Zhihong Beijing, CN 90 849
Qin, Hailin Beijing, CN 4 0
Wang, Wenjie Beijing, CN 55 301
Wu, Lianqiu Beijing, CN 4 1
Yu, Jinqian Beijing, CN 7 1
Zhang, Zhihui Beijing, CN 132 1158

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 23, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00